Blueshift Asset Management, LLC Organon & Co. Transaction History

Blueshift Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$10.95 - $17.32 $134,279 - $212,395	12,263 New	12,263 $176,000
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $148,098 - $216,768	-6,329 Reduced 40.57%	9,270 $217,000
Q2 2022 Aug 12, 2022	BUY	$31.66 - $38.9 $493,864 - $606,801	15,599 New	15,599 $526,000
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $1.53 Million - $1.91 Million	-53,539 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $1.52 Million - $2.03 Million	53,539 New	53,539 $1.62 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.